Esperion Therapeutics, Inc.

BARCLAYS PLC ESPR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

443,339

Value ($000)

1,640

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,640	0.0%	443,339	12/31/2025
2025 Q3	3/31/2026	889	0.0%	335,609	9/30/2025
2025 Q2	2/27/2026	356	0.0%	361,709	6/30/2025
2025 Q1	3/17/2026	340	0.0%	236,133	3/31/2025
2024 Q4	3/19/2026	790	0.0%	359,235	12/31/2024
2024 Q3	3/31/2026	511	0.0%	309,671	9/30/2024
2024 Q2	3/23/2026	344	0.0%	155,162	6/30/2024
2024 Q1	3/24/2026	280	0.0%	104,484	3/31/2024
2023 Q4	3/25/2026	362	0.0%	121,084	12/31/2023
2023 Q3	3/26/2026	87	0.0%	88,984	9/30/2023
2023 Q2	3/30/2026	144	0.0%	103,648	6/30/2023
2023 Q1	3/30/2026	255	0.0%	160,427	3/31/2023
2022 Q4	3/30/2026	1,016	0.0%	163,021	12/31/2022
2022 Q3	11/3/2022	280	0.0%	41,696	9/30/2022
2022 Q2	8/12/2022	178	0.0%	28,079	6/30/2022
2022 Q1	5/16/2022	163	0.0%	35,062	3/31/2022
2021 Q4	2/14/2022	480	0.0%	95,698	12/31/2021
2021 Q3	11/9/2021	585	0.0%	48,606	9/30/2021
2021 Q2	8/13/2021	726	0.0%	34,306	6/30/2021
2021 Q1	5/13/2021	1,066	0.0%	38,020	3/31/2021
2020 Q4	2/11/2021	1,446	0.0%	55,625	12/31/2020
2020 Q3	11/12/2020	441	0.0%	11,861	9/30/2020
2020 Q2	8/12/2020	9,502	0.0%	185,193	6/30/2020
2020 Q1	5/13/2020	5,650	0.0%	179,208	3/31/2020
2019 Q4	2/10/2020	6,440	0.0%	108,013	12/31/2019
2014 Q1	5/15/2014	41	0.0%	2,737	3/31/2014
2013 Q4	2/13/2014	1	0.0%	102	12/31/2013